YBYi-Zhe Bian

Yi-Zhe Bian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yi-Zhe Bian has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Haploinsufficient PRRX1 Variants Conferring Enhanced Susceptibility to Sporadic Atrial Fibrillation

    by Ning Li, Dao-Liang Zhang, Yi-Zhe Bian, Xing-Biao Qiu, Zun-Ping Ke, Ying-Jia Xu, Gao-Feng Zhang, Yi-Qing Yang, Hai-Bo Chen

    Background/Objectives: Atrial fibrillation (AF), the most common type of clinical cardiac arrhythmia worldwide, leads to substantial human morbidity and mortality, and accumulating compelling evidence underscores genetic determinants underlying AF. Recent studies have demonstrated that pathogenic variations in the PRRX1 gene result in familial AF. Nevertheless, whether PRRX1 gene variations have a role in sporadic AF remains indefinite. Methods: A cohort of 398 subjects diagnosed with sporadic AF along with a group of 410 healthy volunteers without a family history of AF were enrolled prospectively. Sequencing exploration of PRRX1 was performed in all study participants. The functional characteristics of the uncovered PRRX1 variations were quantitatively assayed in HeLa cells using dual-reporter genes. Results: Two truncating PRRX1 variations in a heterozygous status, NM_022716.4: c.283C>T; p.(Arg95*) and NM_022716.4: c.328G>T; p.(Glu110*), were discovered in two of the 398 patients suffering from sporadic AF, respectively. Both variations were absent in the 820 control chromosomes. Biochemical measurements revealed that both Arg95* and Glu110* variants failed to transactivate SHOX2 and ISL1, two known genes causative for AF. Additionally, both variations ablated the synergistic activation of SHOX2 by PRRX1 and NKX2.5, another transcription factor causally linked to AF. Conclusions: The present research firstly indicates that haplo-insufficient PRRX1 variants increase genetic predisposition to sporadic AF, which adds new insight to the molecular etiopathogenesis of sporadic AF, highlighting the importance of population-specific genetic research for personalized medicine.

  • Open Access

    Discovery of ETS1 as a New Gene Predisposing to Dilated Cardiomyopathy

    by Zun-Ping Ke, Jia-Ning Gu, Chen-Xi Yang, Xue-Lin Li, Su Zou, Yi-Zhe Bian, Ying-Jia Xu, Yi-Qing Yang

    Background/Objectives: Dilated cardiomyopathy (DCM), defined as dilation and contractile dysfunction of the left or both cardiac ventricles, remains the most common category of primary myocardial disease worldwide. It is the most prevalent cause of chronic heart failure and the most common indication for cardiac transplantation in young subjects. Accumulating evidence increasingly highlights the substantial genetic defects underlying DCM. Nevertheless, the genetic ingredients accountable for DCM in a major percentage of patients remain indefinite. Methods: A multigenerational pedigree suffering from DCM and a total of 276 healthy volunteers employed as controls were recruited from the Chinese Han-ethnicity population. A whole-exome sequencing (WES) assay followed by a Sanger sequencing analysis of the genomic DNAs from the available family members was implemented. Functional characterization of the identified genetic variant was completed by dual-luciferase analysis. Results: A new heterozygous variation in the ETS1 (erythroblast transformation-specific 1) gene, NM_005238.4:c.447T>G;p.(Tyr149*), was identified by WES and validated by Sanger sequencing analysis to co-segregate with DCM in the whole DCM family. This nonsense ETS1 variant was not found in 276 control subjects. Functional examination elucidated that Tyr149*-mutant ETS1 lost the ability to transactivate its downstream target genes CLDN5 (claudin 5) and ALK1 (activin receptor-like kinase 1), two genes crucial for cardiovascular embryonic development and postnatal structural remodeling. Conclusions: The present investigation reveals ETS1 as a new gene predisposed to human DCM and indicates ETS1 haploinsufficiency as an alternative molecular pathogenesis underlying DCM, providing a potential molecular target for genetic counseling and early diagnosis as well as personalized prophylaxis of DCM.


  • Open Access

    Discovery of ETS1 as a New Gene Predisposing to Dilated Cardiomyopathy

    by Zun-Ping Ke, Jia-Ning Gu, Chen-Xi Yang, Xue-Lin Li, Su Zou, Yi-Zhe Bian, Ying-Jia Xu, Yi-Qing Yang

    Background/Objectives: Dilated cardiomyopathy (DCM), defined as dilation and contractile dysfunction of the left or both cardiac ventricles, remains the most common category of primary myocardial disease worldwide. It is the most prevalent cause of chronic heart failure and the most common indication for cardiac transplantation in young subjects. Accumulating evidence increasingly highlights the substantial genetic defects underlying DCM. Nevertheless, the genetic ingredients accountable for DCM in a larger percentage of cases remain indefinite. Methods: In the present research, a multigenerational pedigree suffering from DCM and a cohort of 276 healthy volunteers employed as control individuals were recruited from the Chinese Han-ethnicity population. A whole-exome sequencing (WES) assay followed by a Sanger sequencing analysis of the genomic DNAs from the available family members was implemented. Functional characterization of the identified genetic variant was conducted by utilizing a dual-luciferase analysis system. Results: A novel heterozygous variation in the ETS1 (erythroblast transformation-specific 1) gene, NM_005238.4:c.447T>G;p.(Tyr149*), was identified by WES and validated by Sanger sequencing analysis to co-segregate with DCM in the whole DCM family. This nonsense ETS1 variant was not found in 276 control subjects. Functional decipher elucidated that Tyr149*-mutant ETS1 failed to transactivate its representative target genes CLDN5 (claudin 5) and ALK1 (activin receptor-like kinase 1), two genes crucial for cardiovascular embryonic development and postnatal structural remodeling. Conclusions: The current investigation reveals ETS1 as a novel gene predisposed to human DCM and indicates ETS1 haploinsufficiency as an alternative molecular pathogenesis underlying DCM, providing a potential molecular target for the genetic counseling and early diagnosis as well as personalized prophylaxis of DCM.


  • Open Access

    Chromosomal Location and Identification of TBX20 as a New Gene Responsible for Familial Bicuspid Aortic Valve

    by Yan-Jie Li, Su Zou, Yi-Zhe Bian, Xing-Yuan Liu, Chen-Xi Yang, Li Li, Xing-Biao Qiu, Ying-Jia Xu, Yi-Qing Yang, Ri-Tai Huang

    Background/Objectives: Congenital bicuspid aortic valve (BAV) signifies the most frequent category of congenital cardiovascular anomaly globally, occurring in approximately 0.5–2% of the general population worldwide. BAV is a major cause of thoracic aortopathy, encompassing aortic stenosis, aortic root dilation with regurgitation, aortic dissection, and aortic aneurysms, consequently leading to substantial late-onset morbidity and mortality. Accumulating evidence convincingly demonstrates the strong genetic basis underpinning BAV, though the inheritable reasons responsible for BAV in most patients remain largely obscure. Methods: A genome-wide genotyping with 400 polymorphic genetic markers followed by linkage analysis, haplotype assay, and sequencing analysis of candidate genes was conducted in a 4-generation BAV kindred of 47 individuals. Biochemical assays were performed to evaluate the functional effect of the identified mutation on TBX20. Results: A novel BAV-causative locus was mapped to chromosome 7p14. A sequencing assay of the genes within the mapped chromosomal region (locus) unveiled that only the c.656T>G (p.Ile219Arg) variation of TBX20 was in co-segregation with BAV in the entire pedigree. The missense mutation was not uncovered in 322 healthy persons employed as control individuals. Functional deciphers revealed that the mutation significantly decreased the transcriptional activation of the representative target gene ANP and the binding ability to the ANP promoter and impaired the intranuclear distribution of TBX20. Conclusions: This investigation maps a new genetic locus (chromosome 7p14) linked to BAV and uncovers TBX20 as a novel causative gene for familial BAV, adding more insight into the mechanisms underlying BAV and providing a molecular target for the individualized management of BAV.


  • Open Access

    Chromosomal Location and Identification of TBX20 as a New Gene Responsible for Familial Bicuspid Aortic Valve

    by Yan-Jie Li, Su Zou, Yi-Zhe Bian, Xing-Yuan Liu, Chen-Xi Yang, Li Li, Xing-Biao Qiu, Ying-Jia Xu, Yi-Qing Yang, Ri-Tai Huang

    Congenital bicuspid aortic valve (BAV) signifies the most frequent category of congenital cardiovascular anomaly globally, occurring in approximately 0.5%‒2% of the general population worldwide. BAV is a major cause of thoracic aortopathy, encompassing aortic stenosis, aortic root dilation with regurgitation, aortic dissection, and aortic aneurysms, consequently leading to substantial late-onset morbidity and mortality. Accumulating evidence convincingly demonstrates the strong genetic basis underpinning BAV, though the inheritable ingredients responsible for BAV in most patients remain largely obscure. Here, by the way of genome-wide genotyping with genetic markers, genetic linkage assay, and haplotype analysis in a multigenerational BAV family, a novel BAV-causative locus was mapped to chromosome 7p14. Sequencing assay of the genes within the mapped chromosomal region (locus) unveiled that only the c.656T>G (p.Ile219Arg) variation of TBX20 was in co-segregation with BAV in the entire pedigree. The missense mutation was not uncovered in 322 healthy persons employed as control individuals. Functional deciphers revealed that the mutation significantly decreased the transcriptional activation of the representative target gene ANP and the binding ability to the ANP promoter and impaired the intranuclear distribution of TBX20. This investigation maps a new genetic locus (chromosome 7p14) linked to BAV and uncovers TBX20 as a novel causative gene for familial BAV, adding more insight into the mechanisms underlying BAV and providing a molecular target for the individualized management of BAV.